pavblu

Generic: aflibercept-ayyh

Labeler: amgen, inc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name pavblu
Generic Name aflibercept-ayyh
Labeler amgen, inc
Dosage Form INJECTION, SOLUTION
Routes
INTRAVITREAL
Active Ingredients

aflibercept 2 mg/.05mL

Manufacturer
Amgen, Inc

Identifiers & Regulatory

Product NDC 55513-065
Product ID 55513-065_887609ce-8bc6-4554-b353-23986f6edaac
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761298
Listing Expiration 2026-12-31
Marketing Start 2024-10-28

Pharmacologic Class

Established (EPC)
vascular endothelial growth factor inhibitor [epc]
Mechanism of Action
vascular endothelial growth factor inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 55513065
Hyphenated Format 55513-065

Supplemental Identifiers

RxCUI
2696260 2696267 2696270 2696274
UNII
15C2VL427D
NUI
N0000193543 N0000193542

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pavblu (source: ndc)
Generic Name aflibercept-ayyh (source: ndc)
Application Number BLA761298 (source: ndc)
Routes
INTRAVITREAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/.05mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (55513-065-01) / .05 mL in 1 VIAL
  • 1 VIAL in 1 CARTON (55513-065-96) / .05 mL in 1 VIAL
source: ndc

Packages (2)

55513-065-01 1 VIAL in 1 CARTON (55513-065-01) / .05 mL in 1 VIAL 55513-065-96 1 VIAL in 1 CARTON (55513-065-96) / .05 mL in 1 VIAL

Ingredients (1)

aflibercept (2 mg/.05mL)

Linked Drug Pages (1)

PAVBLU ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVITREAL"], "spl_id": "887609ce-8bc6-4554-b353-23986f6edaac", "openfda": {"nui": ["N0000193543", "N0000193542"], "unii": ["15C2VL427D"], "rxcui": ["2696260", "2696267", "2696270", "2696274"], "spl_set_id": ["c61062f3-80ec-4a20-8c28-46e468592a06"], "pharm_class_epc": ["Vascular Endothelial Growth Factor Inhibitor [EPC]"], "pharm_class_moa": ["Vascular Endothelial Growth Factor Inhibitors [MoA]"], "manufacturer_name": ["Amgen, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (55513-065-01)  / .05 mL in 1 VIAL", "package_ndc": "55513-065-01", "marketing_start_date": "20241028"}, {"sample": true, "description": "1 VIAL in 1 CARTON (55513-065-96)  / .05 mL in 1 VIAL", "package_ndc": "55513-065-96", "marketing_start_date": "20241028"}], "brand_name": "PAVBLU", "product_id": "55513-065_887609ce-8bc6-4554-b353-23986f6edaac", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Vascular Endothelial Growth Factor Inhibitor [EPC]", "Vascular Endothelial Growth Factor Inhibitors [MoA]"], "product_ndc": "55513-065", "generic_name": "aflibercept-ayyh", "labeler_name": "Amgen, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PAVBLU", "active_ingredients": [{"name": "AFLIBERCEPT", "strength": "2 mg/.05mL"}], "application_number": "BLA761298", "marketing_category": "BLA", "marketing_start_date": "20241028", "listing_expiration_date": "20261231"}